Michael J. Farrell's holdings in ResMed reflect a significant commitment to the company. He has experienced a noticeable trajectory in his asset values, especially from late 2019 to the end of 2021. For example, in December 2019, his holdings were...
Michael J. Farrell's holdings in ResMed reflect a significant commitment to the company. He has experienced a noticeable trajectory in his asset values, especially from late 2019 to the end of 2021. For example, in December 2019, his holdings were valued at approximately $47.07 million, and by December 2021, they peaked at an impressive $142.13 million. After this peak, there has been a gradual decline, with current values hovering around $67.38 million. This illustrates a typical fluctuation seen in equity markets, where initial rapid growth can give way to stabilization. Notably, these changes signify Michael’s strong belief in the company's long-term prospects, aligning with ResMed’s vision in the healthcare sector.